Insider Shareholders with Direct Ownership of Cyclerion Therapeutics, Inc. (CYCN)
This section provides a comprehensive overview of the insiders with direct ownership of Cyclerion Therapeutics, Inc. (CYCN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cyclerion Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,098,171 | 0 | 377,385 $867,985 | 8 |
Jan 01, 2024
Added 3.82%
|
|
|
Andreas Busch
Chief Scientific Officer |
125,000 | 0 | 254,704 $585,819 | 1 |
Nov 09, 2020
Added 32.92%
|
|
Mark G Currie
President and CSO |
0 | 20,107 | 251,648 $578,790 | 1 |
Dec 28, 2020
Reduced 7.4%
|
|
Regina Margaret Graul
President |
50,000 | 0 | 100,303 $230,696 | 1 |
Jan 01, 2024
Added 33.27%
|
|
William Huyett
Chief Financial Officer |
0 | 3,827 | 67,590 $155,457 | 1 |
Nov 06, 2020
Reduced 5.36%
|
|
Christopher I Wright
Chief Medical Officer |
0 | 2,637 | 42,728 $98,274 | 1 |
Feb 25, 2021
Reduced 5.81%
|
|
Anjeza Gjino
Chief Financial Officer |
0 | 1,824 | 31,599 $72,677 | 1 |
Feb 25, 2021
Reduced 5.46%
|
| 50,000 | 0 | 30,000 $69,000 | 1 |
Nov 30, 2023
Added 50.0%
|
|
| 20,000 | 0 | 20,000 $46,000 | 1 |
Nov 30, 2023
Added 50.0%
|
|
| 5,000 | 0 | 5,552 $12,769 | 1 |
Nov 30, 2023
Added 47.38%
|
|